Response to article “A retrospective outcome study of 42 patients with chronic fatigue syndrome, 30 of whom has irritable bowel syndrome. Half were treated with oral approaches, and half were treated with faecal microbiome transplantation”

摘要

In comparison to Faecal Microbiota Transplantation (FMT), bac- teriotherapy allows a more select group of bacteria to be infused. Whilst this allows more control over the initial product, the majority of the native gut bacterial species cannot be cultured, and so cannot be in- cluded. Bacteriotherapy is also limited in its ability to supply other aspects of the microbiome (including bacterial debris, proteins, anti- microbial compounds, or bacteriophages) that may be the active agents of the FMT therapy [3]. FMT offers an attractive alternative to bac- teriotherapy as it enables the reintroduction of a complete, stable community of intestinal micro-organisms [2].